PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Dec-2023 Jose Ibietatorremendia to Join Veranova as SVP, General Counsel, and Secretary SVP
12-Dec-2023 Astraveus appoints Dr. Lars Henrik Peeck as Chief Business Development Officer Astraveus
12-Dec-2023 Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP) Biotest AG
12-Dec-2023 DEFENCE RECEIVES FDA APPROVAL FOR PHASE I CLINICAL TRIAL TARGETING SOLID CANCER TUMORS WITH ACCUTOX® Defence Therapeutics Inc.
11-Dec-2023 Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited Tryp Therapeutics Inc.
11-Dec-2023 ImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023 ImmunOs Therapeutics
11-Dec-2023 MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study  MorphoSys AG
08-Dec-2023 Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions Novartis
08-Dec-2023 Lynparza (olaparib) in combination with bevacizumab receives positive final recommendation from NICE for first-line treatment of advanced (stage IIIB-IV) HRD-positive ovarian cancer AstraZeneca
08-Dec-2023 Latest economic data underlines risk of disincentivising UK life sciences growth ABPI
08-Dec-2023 Enhanced Protection for Manufacturing Highly Potent Pharmaceuticals Introduced at New Jersey Facility Experic
08-Dec-2023 Aptar Pharma Continues Global Expansion Program with Opening of New Mumbai Site Aptar Pharma
08-Dec-2023 Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea Sosei Group
07-Dec-2023 Health Canada approves FYB201/Ranopto® (Ranibizumab), a biosimilar to Lucentis® Formycon AG
06-Dec-2023 Rare disease patients are breaking down language and location barriers in a new online community Sciensus
06-Dec-2023 BugBiome wins Discovery Spark life science programme Sciad Newswire
06-Dec-2023 Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company SCHOTT Pharma AG & Co. KGaA
06-Dec-2023 Evotec-partner Jingxin receives approval for EVT201 in China Evotec SE
06-Dec-2023 Cosmo confirms full redemption in cash of €175m Convertible Bonds Cosmo Pharmaceuticals N.V.
05-Dec-2023 Fresenius SE & Co. KGaA: Fresenius retains relief payments for hospitals of up to €300 million (from the current perspective) and is therefore subject to a ban on dividends and bonuses for 2023 Fresenius SE & Co. KGaA